Rapidly Forming Apatitic Mineral in an Osteoblastic Cell Line (UMR 106—01 BSP)

Clark Stanford(University of Iowa), Paul A. Jacobson(University of Iowa), E. D. Eanes(National Institutes of Health), Lois A. Lembke(University of Iowa), Ronald J. Midura(University of Iowa)
Journal of Biological Chemistry
April 1, 1995
Cited by 437Open Access
Full Text

Abstract

This study evaluated a rapid biomineralization phenomenon exhibited by an osteoblastic cell line, UMR 106-01 BSP, when treated with either organic phosphates [β-glycerophosphate (β-GP), Ser-P, or Thr-P], inorganic phosphate (Pi), or calcium. In a dose-dependent manner, these agents (2-10 m M) stimulated confluent cultures to deposit mineral in the cell layer (ED50of ∼ 4.6 m M for β-GP (30 ± 2 nmol Ca2+/μg DNA) and ∼3.8 m M (29 ± 2 nmol Ca2+/μg DNA) for Pi) with a plateau in mineral formation by 20 h (ET50≈ 12-15 h). β-GP or Pitreatment yielded mineral crystals having an x-ray diffraction pattern similar to normal human bone. Alizarin red-S histology demonstrated calcium mineral deposition in the extracellular matrix and what appeared to be intracellular paranuclear staining. Electron microscopy revealed small, needle-like crystals associated with fibrillar, extracellular matrix deposits and intracellular spherical structures. Mineral formation was inhibited by levamisole (ED50≈ 250 μM), pyrophosphate (ED50≈ 1-10 μM), actinomycin C1(500 ng/ml), cycloheximide (50 μg/ml), or brefeldin A (1 μg/ml). These results indicate that UMR 106-01 BSP cells form a bio-apatitic mineralized matrix upon addition of supplemental phosphate. This process involves alkaline phosphatase activity, on-going RNA and protein synthesis, as well as Golgi-mediated processing and secretion. This study evaluated a rapid biomineralization phenomenon exhibited by an osteoblastic cell line, UMR 106-01 BSP, when treated with either organic phosphates [β-glycerophosphate (β-GP), Ser-P, or Thr-P], inorganic phosphate (Pi), or calcium. In a dose-dependent manner, these agents (2-10 m M) stimulated confluent cultures to deposit mineral in the cell layer (ED50of ∼ 4.6 m M for β-GP (30 ± 2 nmol Ca2+/μg DNA) and ∼3.8 m M (29 ± 2 nmol Ca2+/μg DNA) for Pi) with a plateau in mineral formation by 20 h (ET50≈ 12-15 h). β-GP or Pitreatment yielded mineral crystals having an x-ray diffraction pattern similar to normal human bone. Alizarin red-S histology demonstrated calcium mineral deposition in the extracellular matrix and what appeared to be intracellular paranuclear staining. Electron microscopy revealed small, needle-like crystals associated with fibrillar, extracellular matrix deposits and intracellular spherical structures. Mineral formation was inhibited by levamisole (ED50≈ 250 μM), pyrophosphate (ED50≈ 1-10 μM), actinomycin C1(500 ng/ml), cycloheximide (50 μg/ml), or brefeldin A (1 μg/ml). These results indicate that UMR 106-01 BSP cells form a bio-apatitic mineralized matrix upon addition of supplemental phosphate. This process involves alkaline phosphatase activity, on-going RNA and protein synthesis, as well as Golgi-mediated processing and secretion.


Related Papers

No related papers found

Powered by citation graph analysis